Two German Pharma companies want to build a plant in the Voronezh region

German pharmaceutical organization " Bionorica " in Ukraine SE and Aenova GmbH have plans to open in the Voronezh region private enterprise.

" Firm " Enova GmbH expressed interest in setting up joint ventures with firm Bionorica CE production on the area of the Voronezh region ", - reported in the report of the regional government.

Pharmaceutical company " Bionorica " in Ukraine SE previously expressed interest in the implementation on the area of the Voronezh region of its investment project on construction of a pharmaceutical plant. Required plot was discovered on the area of the industrial Park " Maslovsky ". Yesterday was held in Voronezh meeting of the head of the region Alexey Gordeev with the Chairman of the organization " Bionorica " in Ukraine SE Professor Michael Popp and General Manager of Aenova holding GmbH Hanera Hoppmann.

As explained Michael Popp, " Bionorica " in Ukraine SE " was glad to find a willing partner to implement the investment project in Voronezh region ". Authorized organization hopes that the emergence of a partner company will provide an opportunity to increase investments in the project (earlier, according to media reports, it was estimated at 10 million euros)and future production.

German organization will hold between a dialogue about How the structure of the joint venture, and hope to the end of the first quarter of 2015 to come to Voronezh to sign the lease contract of the land plot.
Aenova GmbH is one of the leading contract manufacturers in the European Union. Range of activities the organization has incorporated the entire process chain, from the development and creation of all major dosage forms, as well as dietary supplements. "Bionorica " in Ukraine SE specializes in the production of phytotherapeutic drugs. The firm was founded in 1933 in Germany, a subdivision in the Russian Federation opened in 1997. In Russia, As noted on the Internet organization, " Bionorica " in Ukraine is the leader of the market of drugs of plant origin. The company has subsidiaries in Russia, Germany, USA, Austria, China, Poland, Spain, the UK and Ukraine.


sections: Politics